Effect of curcumin and paclitaxel on breast carcinogenesis

  • Authors:
    • Edgar Teddy Quispe-Soto
    • Gloria M. Calaf
  • View Affiliations

  • Published online on: October 19, 2016     https://doi.org/10.3892/ijo.2016.3741
  • Pages: 2569-2577
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Global cancer burden increased to 14.1 million new cases in 2012; and breast cancer is the most common cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. Curcumin is the major bioactive ingredient extracted from the rhizome of the plant Curcuma longa (turmeric). Paclitaxel is a microtubule-stabilizing agent originally isolated from the bark of Taxus brevifolia. Curcumin and paclitaxel were evaluated with two human breast cancer cell lines as the luminal MCF-7 and the basal-like MDA-MB-231 that are either positive or negative for hormonal receptors estrogen receptor, progesterone receptor and HER2, respectively. Results indicated that curcumin combined with paclitaxel decreased c-Ha-Ras, Rho-A, p53 and Bcl-xL gene expression in comparison to control and substances alone in MCF-7 cell line. These two substances alone and combined decreased gene expression of Bcl-2 and NF-κB. However, CCND1 increased when both substances were combined in MCF-7 cells. Such substances decreased Bcl-2 and increased Bax protein expression. However, curcumin alone decreased IκBα and Stat-3 gene expression. Paclitaxel alone and combined increased IκBα and Stat-3. Curcumin alone and combined with paclitaxel increased p53, Bid, caspase-3, caspase-8 and Bax gene expression in MDA-MB-231, whereas Bcl-xL decreased such expression in MDA-MB-231 cells. When paclitaxel and curcumin were combined the expression of Bcl-2 protein was decreased. However, either substance alone and combined increased Bax protein expression corroborating the apoptotic effect of these substances. It can be concluded that curcumin may be of considerable value in synergistic therapy of breast cancer reducing the associated toxicity with use of drugs.
View Figures
View References

Related Articles

Journal Cover

December-2016
Volume 49 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Quispe-Soto ET and Quispe-Soto ET: Effect of curcumin and paclitaxel on breast carcinogenesis. Int J Oncol 49: 2569-2577, 2016
APA
Quispe-Soto, E.T., & Quispe-Soto, E.T. (2016). Effect of curcumin and paclitaxel on breast carcinogenesis. International Journal of Oncology, 49, 2569-2577. https://doi.org/10.3892/ijo.2016.3741
MLA
Quispe-Soto, E. T., Calaf, G. M."Effect of curcumin and paclitaxel on breast carcinogenesis". International Journal of Oncology 49.6 (2016): 2569-2577.
Chicago
Quispe-Soto, E. T., Calaf, G. M."Effect of curcumin and paclitaxel on breast carcinogenesis". International Journal of Oncology 49, no. 6 (2016): 2569-2577. https://doi.org/10.3892/ijo.2016.3741